Arcus Biosciences Company
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Investors
Founded Date:
2015
Total Funding:
$226.7M
Investor Type:
N/A
Employee Number:
101-250
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
N/A
Technology:
Anti-infective Drugs
Last Funding Type:
Series C
Investors Number:
17
Industry:
PharmTech
Headquarters:
Hayward, California, United States
Estimated Revenue:
$1M to $10M